daunorubicin has been researched along with Lymphoma, Large-Cell, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, S; Biswas, A; Devnani, B; Sharma, A; Sharma, MC | 1 |
Dzhulakian, UL; Egorova, EK; Giliazitdinova, EA; Gorgidze, LA; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Lutsenko, IN; Magomedova, AU; Mar'in, DS; Margolin, OV; Ryzhikova, NA; Samoĭlova, RS; Valiev, TT; Vinogradova, IuE; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE | 1 |
2 other study(ies) available for daunorubicin and Lymphoma, Large-Cell, Anaplastic
Article | Year |
---|---|
Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Paranasal Sinuses; Prednisolone; Prognosis; Radiotherapy, Conformal; Vincristine; Young Adult | 2019 |
[Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vincristine | 2008 |